Check-Cap Ltd. (NASDAQ:CHEK) Sees Significant Decline in Short Interest

Check-Cap Ltd. (NASDAQ:CHEK) was the target of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 165,500 shares, a drop of 13.4% from the May 31st total of 191,100 shares. Currently, 3.8% of the company’s shares are sold short. Based on an average daily trading volume, of 247,400 shares, the days-to-cover ratio is currently 0.7 days.

Analyst Ratings Changes

Separately, StockNews.com started coverage on Check-Cap in a report on Wednesday, June 26th. They issued a “sell” rating on the stock.

Check-Cap Stock Up 1.0 %

Shares of NASDAQ CHEK traded up $0.02 during midday trading on Monday, hitting $2.03. The stock had a trading volume of 53,370 shares, compared to its average volume of 138,679. Check-Cap has a 1-year low of $1.78 and a 1-year high of $4.63. The company has a market capitalization of $11.88 million, a price-to-earnings ratio of -0.68 and a beta of 0.40. The company has a fifty day moving average price of $2.20 and a 200 day moving average price of $2.21.

Check-Cap (NASDAQ:CHEK) last posted its earnings results on Wednesday, May 15th. The medical research company reported ($0.62) earnings per share (EPS) for the quarter. On average, research analysts forecast that Check-Cap will post -0.68 EPS for the current year.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.